We are delighted to announce that Professor Jennifer Van Eyk has today joined the Atturos Advisory Board. Jennifer is currently Director of the Advanced Clinical Biosystems Institute in the Department of Biomedical Sciences in Cedars-Sinai Medical Centre, Los Angeles, California. Her research lab there focusses on the development of clinically robust circulating biomarkers and their measurement by targeted MS-based quantitative measurements. The group are currently investigating the molecular basis behind a variety of cardiovascular disorders, with active projects ranging from basic discovery research to clinical analytical evaluations.
Jennifer has been involved in a number of startups, licensing of IP to large diagnostic companies and currently is establishing a contract mass spectrometry laboratory and a synergistic CAP/CLIA speciality laboratory. Her’s considerable mass spectrometry-based expertise to deciphering the role protein expression patterns and modifications play in disease progression will be invaluable to the development of the OCProDx test.